AI-Designed Universal Coronavirus Vaccine Passes Human Trials
An experimental universal coronavirus vaccine designed by artificial intelligence has successfully completed its first human clinical trial. According to peer-reviewed data published in the Journal of Infection, the Phase 1 trial involving 39 healthy adults demonstrated a 100 per cent safety profile with zero serious adverse reactions, signaling a potential shift toward unified viral defense … Read more